PHARMACEUTICAL INDUSTRY

Innovators in the pharmaceutical industry face particularly close antitrust scrutiny from the European Commission and national competition authorities. The authorities’ focus is wide, covering such matters as agreements delaying entrance of generic products to a market, the impact distribution schemes may have on competition, parallel import and refusal to deal.

Our lawyers have extensive experience in advising producers of innovative drugs and medical products in strategic matters and in assisting pharmaceutical businesses on an ongoing basis.

Contact: Małgorzata Modzelewska de Raad

 

  INDUSTRIES

© 2019   PRIVACY POLICY   •   CONTACT
designed by MOUTON interactive